These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11036190)

  • 1. Substance P modulation of striatal dopamine outflow is determined by M(1) and M(2) muscarinic receptors in male wistar rats.
    Khan S; Whelpton R; Michael-Titus AT
    Neurosci Lett; 2000 Nov; 293(3):179-82. PubMed ID: 11036190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N- and C-terminal substance P fragments modulate striatal dopamine outflow through a cholinergic link mediated by muscarinic receptors.
    Khan S; Grogan E; Whelpton R; Michael-Titus AT
    Neuroscience; 1996 Aug; 73(4):919-27. PubMed ID: 8809811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic antagonists in substantia nigra influence the decarboxylation of L-dopa in striatum.
    Izurieta-Sánchez P; Sarre S; Ebinger G; Michotte Y
    Eur J Pharmacol; 2000 Jul; 399(2-3):151-60. PubMed ID: 10884514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscarinic modulation of striatal dopamine, glutamate, and GABA release, as measured with in vivo microdialysis.
    Smolders I; Bogaert L; Ebinger G; Michotte Y
    J Neurochem; 1997 May; 68(5):1942-8. PubMed ID: 9109520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism: an in vivo microdialysis study comparing normal and 6-hydroxydopamine-lesioned rats.
    De Klippel N; Sarre S; Ebinger G; Michotte Y
    Brain Res; 1993 Dec; 630(1-2):57-64. PubMed ID: 8118706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple muscarinic acetylcholine receptor subtypes modulate striatal dopamine release, as studied with M1-M5 muscarinic receptor knock-out mice.
    Zhang W; Yamada M; Gomeza J; Basile AS; Wess J
    J Neurosci; 2002 Aug; 22(15):6347-52. PubMed ID: 12151512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actions of methoctramine, a muscarinic M2 receptor antagonist, on muscarinic and nicotinic cholinoceptors in guinea-pig airways in vivo and in vitro.
    Watson N; Barnes PJ; Maclagan J
    Br J Pharmacol; 1992 Jan; 105(1):107-12. PubMed ID: 1596672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of muscarinic receptors involved in tracheal CGRP release.
    Hua XY; Back SM; Yaksh TL
    Neuroreport; 1994 Oct; 5(16):2133-6. PubMed ID: 7865762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscarinic receptor blockade increases basal acetylcholine release from striatal slices.
    Dolezal V; Wecker L
    J Pharmacol Exp Ther; 1990 Feb; 252(2):739-43. PubMed ID: 2313598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. M1 muscarinic receptors contribute to, whereas M4 receptors inhibit, dopamine D1 receptor-induced [3H]-cyclic AMP accumulation in rat striatal slices.
    Sánchez-Lemus E; Arias-Montaño JA
    Neurochem Res; 2006 Apr; 31(4):555-61. PubMed ID: 16758365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscarinic receptor modulation of acetylcholine release from rat cerebral cortex and hippocampus.
    Vannucchi MG; Pepeu G
    Neurosci Lett; 1995 Apr; 190(1):53-6. PubMed ID: 7624055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of muscarinic acetylcholine receptors (M1-, M2-, M3- and M4-type) in the neuromuscular junction of the newborn and adult rat.
    Garcia N; Santafé MM; Salon I; Lanuza MA; Tomàs J
    Histol Histopathol; 2005 Jul; 20(3):733-43. PubMed ID: 15944922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtypes of muscarinic receptors regulating gallbladder cholinergic contractions.
    Parkman HP; Pagano AP; Ryan JP
    Am J Physiol; 1999 May; 276(5):G1243-50. PubMed ID: 10330016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galanin stimulates striatal acetylcholine release via a mechanism unrelated to cholinergic receptor stimulation.
    Pramanik A; Ogren SO
    Regul Pept; 1993 Jun; 45(3):353-62. PubMed ID: 7688904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance P-(1-7) and substance P-(5-11) locally modulate dopamine release in rat striatum.
    Khan S; Brooks N; Whelpton R; Michael-Titus AT
    Eur J Pharmacol; 1995 Aug; 282(1-3):229-33. PubMed ID: 7498281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscarinic receptors involved in airway vascular leakage induced by experimental gastro-oesophageal reflux.
    Cui YY; Zhu L; Wang H; Advenier C; Chen HZ; Devillier P
    Life Sci; 2008 Apr; 82(17-18):949-55. PubMed ID: 18367213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism in freely moving rats.
    Xu M; Mizobe F; Yamamoto T; Kato T
    Brain Res; 1989 Aug; 495(2):232-42. PubMed ID: 2765928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained unilateral blockade of rat striatal M(1) muscarinic receptors with m1-toxin1 in vivo.
    Liang J; Gutierrez-Ford C; Potter LT
    Brain Res; 2001 Dec; 921(1-2):211-8. PubMed ID: 11720728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscarine receptor-mediated modulation of [3H]dopamine and [14C]acetylcholine release from rat neostriatal slices: selective antagonism by gallamine but not pirenzepine.
    Schoffelmeer AN; Van Vliet BJ; Wardeh G; Mulder AH
    Eur J Pharmacol; 1986 Sep; 128(3):291-4. PubMed ID: 3792444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for facilitatory and inhibitory muscarinic receptors on postganglionic sympathetic nerves in mouse isolated atria.
    Cost M; Majewski H
    Br J Pharmacol; 1991 Apr; 102(4):855-60. PubMed ID: 1713109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.